We present evidence that the genetic ablation of Smox results in decreased progression to gastric cancer, suppression of proinflammatory, chemokine, T-cell associated, and carcinogenic genes, and reduced cell proliferation and DNA damage during H. pylori infection. This evidence concerns the gene SMOX and gastric cancer.